Use of non-ionic contrast media (CM) in coronary arteriography has been reported to cause transient cortical blindness, confusion, amnesia and very rare focal deficits. We report a 69-year old patient with stable angina pectoris who underwent coronary angioplasty with stent placement due to in-stent thrombosis of the right coronary artery and developed stroke symptoms with radiological suspicion of subarachnoid hemorrhage. No vascular malformations were detected on CT cerebral angiography. Dual antiplatelet treatment was continued. Complete neurological recovery was observed within 48 hours post angiography. As observed with repeated CT scans, sulcal hyperdensities mostly faded after 24 hours and totally disappeared within 7 days when she was discharged home. Our case shows transient neurological symptoms and rapid disappearing of sulcal hyperdensities, suggesting temporary blood brain barrier disruption, consequential cerebral infarction and contrast media extravasation as the main mechanisms which allowed us to treat the patient with dual antiplatelet treatment.
INTRODUCTION
Use of non-ionic contrast media (CM) in coronary arteriography has been reported to cause transient cortical blindness, confusion, amnesia and very rare focal deficits [1, 2] . The proposed mechanisms of neurotoxicity are disruption of the blood-brain barrier (BBB) and a direct neurotoxic effect by CM [3] . Abnormal contrast enhancement on brain computed tomography (CT) scan after diagnostic or interventional angiography is not rare and has known to be induced by temporary BBB disruption from CM [3] . The aim of this case report is to show mimicking subarachnoid hemorrhage (SAH) caused by contrast extravasation due to dysfunction of BBB in acute ischemic stroke.
CASE REPORT
A 69-year old woman, with stable angina pectoris, arterial hypertension, diabetes and stent placement in right coronary artery (RCA) eight years earlier, underwent transfemoral coronary angioplasty with recanalization and stent placement in RCA due to subtotal in-stent restenosis. Additional treatment included 10 000 IU heparin, aspirin 100 mg and clopidogrel 600 mg. A half an hour after the procedure, she suffered chest pain with aphasia, confusion and right hand paresis. She underwent second interventional procedure with recanalization and two stents placement due to confirmed acute in-stent thrombosis, followed by eptifibatid bolus and infusion. A non-ionic contrast iohexol was used in both procedures, in an amount of 350 milliliters both times. Immediately after, she underwent neurological examination which revealed recovery of aphasia and persistence of right central facial palsy, right mild hemiparesis and hemihypoesthesia with facilitated tendon reflexes. Brain CT showed acute cortical and subcortical frontoparietal cerebral infarction with hyperdense (50-75 HU) content filling the sulci of left hemisphere, which was diagnosed as SAH ( Fig. 1a) . At this time the patient was referred to our Stroke and Intensive Care Unit. No vascular malformations were detected on CT cerebral angiography. To consider other causes of SAH, it is valuable to notice that prior to this event, she was not treated with anticoagulation therapy or steroids and she did not have any clinical signs which would corroborate the diagnosis of vasculitis or reversible cerebral vasoconstriction syndrome. There were no signs of vasospasm during transcranial doppler ultrasonography. Dual antiplatelet treatment including aspirin and clopidogrel was continued. Complete neurological recovery was observed within 48 hours after angiography. As observed with repeated CT scans, cerebral infarction was sequentially detected opposite to sulcal hyperdensities that mostly faded after 24 hours (Fig. 1b) and totally disappeared within 7 days when she was discharged home (Fig. 1c) . 
DISCUSSION
In-hospital cerebrovascular accident after per-cutaneous coronary intervention (PCI) occurs in about 0.30% of procedure [4] . Our case shows transient neurological symptoms and rapid disappearing of sulcal hyperdensities, suggesting temporary BBB disruption, consequential cerebral infarction and CM extravasation as the main mechanisms that allowed us to treat the patient with dual antiplatelet therapy. The usage of dual antiplatelet therapy was necessary in treatment of coronary disease and ischemic stroke prevention. The coexistence of SAH remains unlikely. Although the specificity of CT for SAH is very high, physicians should be aware of rare false positive findings [5] . CM extravasation could mimic radiologically SAH which is likely to occur in cases in which more than one revascularization is performed [6] . The density of the lesion measured in Hounsfields units (HU) could be a useful distinguishing characteristic, which is confirmed in a recently published review of 53 published cases of "contrast induced encephalopathy" noting that blood density is ranging between 40 and 60 HU and contrast media usually between 100 and 300 HU [7] . Magnetic resonance imaging (MRI)-derived apparent diffusion coefficient (ADC) was shown as a reliable imaging modality that differentiates contrast extravasation from cerebral ischemia [8] . Other authors have suggested dual energy scanning (DECT) in distinguishing intracranial hemorrhage from iodinated contrast extravasation or staining [9] . In the absence of those techniques, in stable patient with resolving symptoms, standard of care could be repeated follow-up imaging [10] , usually showing that contrast staining generally washes out within 24-48 hours, while hemorrhage persists for days to weeks [9] . In our case, brain MR was not performed because recent stent placement (hospital protocol does not allow MRI within 3 months after stent placement) [11] and clinical improvement with contrast clearance on serial brain CTs. The spinal puncture was not performed based on our opinion that there would be a high risk for spinal bleeding without a real benefit to the patient. Physicians who treat the patients with cerebrovascular complications after PCI, and who do not have possibility of the proposed novel MRI and CT techniques, could find our case report helpful in making their clinical decisions. A careful follow-up, especially in a stable patient with resolving neurological deficit, would be reasonable in order to postpone or completely avoid potentially harmful additional CM administration and/or spinal puncture with high risk of bleeding, in this group of patients recently treated with multiple antithrombotic drugs. 
